SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
wla(warner lambert)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
942 16 0 WLA
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
442 Barron's Online has an article today on how big blue-chip U.S. drug stocks David GarrisonD-1/20/1999
441 Greg, thanks for WLA post. Based on the projected earnings in the post of $1.4Mark Peterson CPA-1/20/1999
440 1/20/99 Warner Lambert is Fine Despite Rezulin Controversy: Buy On JanuaGreg Jenkins-1/20/1999
439 12/15/98 Warner-Lambert Responds to Rezulin controversy Warner Lambert rGreg Jenkins-1/20/1999
438 12/9/98 Warner Lambert: Concern Regarding Diabetes Drug Rezulin The Los Greg Jenkins-1/20/1999
437 Here are the comments from individual investor magazine website. iionline.com.Greg Jenkins-1/20/1999
436 I will post the other comments from iionline tonight. I also have the opinion Greg Jenkins-1/20/1999
435 Greg, thanks for the II report. This is a good entry price for long term invesAnthony Wong-1/20/1999
434 I just got in at $69. The following is from Individual Investor website. iionGreg Jenkins-1/20/1999
433 Not much downside left, John. We'll see a rebound by earnings week latest.Anthony Wong-1/20/1999
432 added to my position this morning @ 66John Carragher-1/20/1999
431 Warner-Lambert Falls for 2nd Day on Rezulin Setbacks (Update2) BloombergAnthony Wong-1/20/1999
430 Nothing new really other than that they are rehashing the story: Wednesday JanAnthony Wong-1/20/1999
429 There is no reward without risk, but WLA's upcoming earnings announcement oMark Peterson CPA-1/20/1999
428 Quonnie, from PFE's earnings report: Lipitor Introduction In 1997, PAnthony Wong-1/19/1999
427 Anthony I finally trapped this drug stock into my portfolio.. Been tracking it Quonnie-1/19/1999
426 NEW YORK (Dow Jones)--Shares of Warner-Lambert Co. (WLA) fell nearly 5% TueAnthony Wong-1/19/1999
425 Aaron, you may wish to refer to the Bloomberg article at Post# 407: Message 732Anthony Wong-1/19/1999
424 We know that the FDA will be reviewing Rezulin one day in March per the releaseAARON DIDICH-1/19/1999
423 Warner-Lambert Cut to 'Outperform' at Salomon Smith Barney BloomAnthony Wong-1/19/1999
422 Warner-Lambert Reiterated 'Buy' at PaineWebber, target $93 BloomAnthony Wong-1/19/1999
421 twt, currently Rezulin has a market share of 9% while Lipitor's market sharAnthony Wong-1/19/1999
420 Hi Anthony, is Rezulin a BIG contributor to WLA's bottom line? I am nottwt-1/18/1999
419 Mark--- I am in long as it is impossible to be nimble in the mkt at this time. Captain Jack-1/17/1999
418 Captain Jack---Reviewed the WLA threads back to the beginning of December, 1998Mark Peterson CPA-1/17/1999
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News